The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).
John Paoletti and his nursing colleagues realized something was wrong with the needles used to start patients’ IV catheters: When they pulled the needle out of a patient’s arm, the needle didn’t ...
LANL officials Thom Mason and Angela Mielke answered questions from the community at a virtual Zoom town hall.